leisure time -WSS

leisure time

author：leisure time 2025-09-30 18:00:10 - browse：123

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： New weight loss drugs work. But how can they best be used?

knowledge

WSS

Some top drug companies are starting to take action on climate

Setback for rare diseases as Taysha Gene Therapies pulls back

Stop Congress from blocking public access to science

Federal weight loss drug coverage is 30 years out of date

Antibiotic resistance and the global rise in human conflict

3 medical device trends to watch in 2024

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Medical records are filled with copy

Setback for rare diseases as Taysha Gene Therapies pulls back

At least 13 dead in Texas as scorching temps continue

3 trends to watch in health tech's hiring outlook for 2024

The high cost of giving birth even with insurance

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Novavax promises a turnaround & Lilly roils the obesity market

6 solutions to address cancer drug shortages and others

Activists slam private health insurers over coverage restrictions

The United States is paying nearly triple for new Covid vaccines

knowledge

UCB departs biotech trade group BIO

Burning questions for the 2024 JPM Healthcare Conference

WHO recommends second malaria vaccine

What will Novo Nordisk's VC do with its influx of cash?

White House finalizes ITC's import ban of latest Apple Watches

Some top drug companies are starting to take action on climate

explore

knowledge

explore

explore